Intracellular ESAT-6 vs flow cytometric analysis of CD4+IFN-γ+ cells for the diagnosis of mycobacterium tuberculosis infection in immunosuppressed patients

Andreas Anastasopoulos (Athens, Greece), Chrysovalantis V. Papageorgiou, Angelos D. Gritzapis, Maria Ploussi, Michail Leventopoulos, Andreas Anastasopoulos, Simona Karabela, Kyriakos Fotiadis, Evangelos Vogiatzakis, Vassilis Tsilivakos, Nikolaos Poulakis

Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andreas Anastasopoulos (Athens, Greece), Chrysovalantis V. Papageorgiou, Angelos D. Gritzapis, Maria Ploussi, Michail Leventopoulos, Andreas Anastasopoulos, Simona Karabela, Kyriakos Fotiadis, Evangelos Vogiatzakis, Vassilis Tsilivakos, Nikolaos Poulakis. Intracellular ESAT-6 vs flow cytometric analysis of CD4+IFN-γ+ cells for the diagnosis of mycobacterium tuberculosis infection in immunosuppressed patients. Eur Respir J 2016; 48: Suppl. 60, 2697

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Flow cytometric immune profiling in infliximab-associated tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Evaluation of IFNgamma release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013

Verification of pulmonary tuberculosis in HIV-infected patients with low CD4
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Tuberculosis-specific CD8 cells in HLA A*02-positive TB and LTBI patients
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Clinical nalysis of glycopeptidolipid core antigen IgA antibodies for cases in which it is difficult to obtain a definite diagnosis of mycobacterium avium complex pulmonary disease
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex pulmonary disease
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

LATE-BREAKING ABSTRACT: Intracellular ESAT-6: a new biomarker of mycobacterium tuberculosis infection?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Immunophenotypic characterisation of peripheral blood mononuclear cells in patients with MDR pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Serodiagnosis of mycobacterium avium-complex pulmonary disease using anti-glycopeptidolipid core antigen IgA antibody
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs
Source: Eur Respir J 2009; 34: 702
Year: 2009